ThriveRx Revenue and Competitors
Estimated Revenue & Valuation
- ThriveRx's estimated annual revenue is currently $2.3M per year.
- ThriveRx's estimated revenue per employee is $150,600
Employee Data
- ThriveRx has 15 Employees.
- ThriveRx grew their employee count by -6% last year.
ThriveRx's People
Name | Title | Email/Phone |
---|
ThriveRx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $59.6M | 221 | 28% | N/A | N/A |
#2 | $7.6M | 38 | 9% | N/A | N/A |
#3 | $260.4M | 741 | 3% | N/A | N/A |
#4 | $2.6M | 17 | -32% | N/A | N/A |
#5 | $2.4M | 16 | -24% | N/A | N/A |
#6 | $28.6M | 114 | 18% | N/A | N/A |
#7 | $59.4M | 215 | 6% | N/A | N/A |
#8 | $11.5M | 51 | 9% | N/A | N/A |
#9 | $135.9M | 433 | 0% | N/A | N/A |
#10 | $22.6M | 90 | 30% | N/A | N/A |
What Is ThriveRx?
ThriveRx is the nutrition division of Diplomat Specialty Infusion Group, a home infusion pharmacy providing therapies for consumers across the United States. Our mission is to provide quality care that fosters independence and empowers consumers and their families. We support home parenteral and enteral nutrition (HPEN) consumers with their therapies and everyday living. Certified in nutrition support and intravenous care, our teams of nurses, dietitians, and pharmacists help consumers manage their home parenteral and enteral nutrition. We offer a wealth of resources to help you and your family connect with others on nutrition support, learn more about your therapy, and improve quality of life. The ThriveRx nutrition team has received the Clinical Nutrition Team of Distinction award from the American Society for Parenteral and Enteral Nutrition (ASPEN).
keywords:Food & Beverages,Healthcare,Healthcare Providers,PharmaceuticalsN/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 15 | 7% | N/A |
#2 | $1.3M | 15 | 7% | N/A |
#3 | $1.3M | 15 | N/A | N/A |
#4 | $1.3M | 15 | 7% | N/A |
#5 | $1.3M | 15 | 36% | N/A |